These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
816 related articles for article (PubMed ID: 37522769)
21. MULTIPLE KERATINOCYTIC CANCERS AFTER ENALAPRIL/LOSARTAN INTAKE: POTENTIAL LINKS TO DRUG MEDIATED NITROSOGENESIS/CARCINOGENESIS: MELOLABIAL ADVANCED FLAP AND UNDERMINING SURGERY AS OPTIMAL THERAPEUTIC APPROACH. Tchernev G Georgian Med News; 2023 Nov; (344):196-199. PubMed ID: 38236123 [TBL] [Abstract][Full Text] [Related]
22. MANAGEMENT OF RISKS OF ADVERSE DRUG REACTIONS ACCORDING TO ADR REPORT FORM DATA FROM LVIV REGION HEALTHCARE FACILITIES IN 2022. Stepaniuk N; Piniazhko O; Poshyvak O; Bessarab T; Hudz N; Gavriluk I Georgian Med News; 2023; (340-341):76-80. PubMed ID: 37805878 [TBL] [Abstract][Full Text] [Related]
23. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
24. (N-NITROSO) PROPAFENONE INDUCED ADVANCED NODULAR MELANOMA-FIRST REPORTED CASE IN THE WORLD LITERATURE: THE INEXTRICABLE LINKS BETWEEN THE PHOTOCARCINOGENESIS, DRUG RELATED NITROSOGENESIS AND PHARMACO-ONCOGENESIS. Tchernev G Georgian Med News; 2024 Feb; (347):34-37. PubMed ID: 38609110 [TBL] [Abstract][Full Text] [Related]
25. Drug Expenditure, Price, and Utilization in the U.S. Medicaid: A Trend Analysis for SSRI and SNRI Antidepressants from 1991 to 2018. Alrasheed M; Hincapie AL; Guo JJ J Ment Health Policy Econ; 2021 Mar; 24(1):3-11. PubMed ID: 33739932 [TBL] [Abstract][Full Text] [Related]
26. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults. Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028 [TBL] [Abstract][Full Text] [Related]
27. NEIGHBOURING MELANOMAS AND DYSPLASTIC NEVUS DEVELOPING SIMULTANEOUSLY AFTER CANDESARTAN INTAKE: NITROSAMINE CONTAMINATION/ AVAILABILITY AS MAIN CAUSE FOR SKIN CANCER DEVELOPMENT AND PROGRESSION. Tchernev G Georgian Med News; 2023 Mar; (336):104-107. PubMed ID: 37166890 [TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. Israili ZH J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085 [TBL] [Abstract][Full Text] [Related]
29. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder. Foster RH; Goa KL CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224 [TBL] [Abstract][Full Text] [Related]
30. What can we do to make antihypertensive medications taste better for children? Ferrarini A; Bianchetti AA; Fossali EF; Faré PB; Simonetti GD; Lava SA; Bianchetti MG Int J Pharm; 2013 Nov; 457(1):333-6. PubMed ID: 23906666 [TBL] [Abstract][Full Text] [Related]
31. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths. Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533 [TBL] [Abstract][Full Text] [Related]
32. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Brocco M; Dekeyne A; Veiga S; Girardon S; Millan MJ Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558 [TBL] [Abstract][Full Text] [Related]
33. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test. Nic Dhonnchadha BA; Ripoll N; Clénet F; Hascoët M; Bourin M Psychopharmacology (Berl); 2005 May; 179(2):418-29. PubMed ID: 15821956 [TBL] [Abstract][Full Text] [Related]
34. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system. Scheen AJ Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153 [TBL] [Abstract][Full Text] [Related]
35. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Felton TM; Kang TB; Hjorth S; Auerbach SB Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903 [TBL] [Abstract][Full Text] [Related]
36. Antidepressants and the risk of hyponatremia: a class-by-class review of literature. De Picker L; Van Den Eede F; Dumont G; Moorkens G; Sabbe BG Psychosomatics; 2014; 55(6):536-47. PubMed ID: 25262043 [TBL] [Abstract][Full Text] [Related]
37. [Angiotensin II type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD)]. Shibasaki Y; Nishiue T; Masaki H; Matsubara H; Iwasaka T Nihon Rinsho; 2002 Oct; 60(10):1992-8. PubMed ID: 12397697 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture. Gao XM; Tsai A; Al-Sharea A; Su Y; Moore S; Han LP; Kiriazis H; Dart AM; Murphy AJ; Du XJ Cardiovasc Drugs Ther; 2017 Apr; 31(2):145-156. PubMed ID: 28204966 [TBL] [Abstract][Full Text] [Related]
39. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function. Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536 [TBL] [Abstract][Full Text] [Related]